Literature DB >> 30546464

Focal positivity of immunohistochemical markers for pulmonary squamous cell carcinoma in primary pulmonary choriocarcinoma: A histopathological study.

Susumu Matsukuma1,2, Kiyohaya Obara3, Yoshitaka Utsumi1, Kosuke Miyai1, Hiroaki Takeo1, Yoshiro Oshika3, Koji Sensaki3.   

Abstract

Cytokeratin 5/6 (CK5/6), p63, and p40 are commonly used as immunohistochemical markers for squamous cell carcinoma (SqCC) of the lung. To elucidate their positivity in primary pulmonary choriocarcinoma (PPC), the present study examined 4 PPCs, including 1 surgically removed PPC and 3 postmortem PPCs. All PPCs consisted of nested cytotrophoblastic tumor cells and occasional syncytiotrophoblastic tumor cells although 1 surgically removed PPC was markedly affected by pre-operative therapy-associated necrosis and 3 postmortem PPCs coexisted with adenocarcinoma. In 1 surgical case, a pre-operative biopsy specimen of PPC contained a few polygonal tumor cells, which mimicked SqCC and exhibited focal p40+ features. Nuclear p63+ and p40+ features of cytotrophoblast-like polygonal tumor cells were focally observed in 3 PPCs (75%) and 2 PPCs (50%), respectively. CK5/6+ trophoblastic tumor cells were focally identified in 1 PPC. Additionally, in 2 other PPCs, CK5/6+ tumor cells were scattered in choriocarcinomatous areas, but possible intermingling of CK5/6+ adenocarcinoma cells could not be ruled out. The results emphasized that PPCs could mimic SqCC morphologically and immunohistochemically, although PPC was an extremely rare neoplasm. Surgical pathologists should be aware of this diagnostic pitfall when encountering a few squamous marker-positive polygonal tumor cells within hemorrhagic necrotic biopsy specimens from lung tumors.

Entities:  

Keywords:  choriocarcinoma; cytokeratin 5/6; immunohistochemistry; lung; p40; p63; primary pulmonary choriocarcinoma; squamous cell carcinoma

Year:  2018        PMID: 30546464      PMCID: PMC6256337          DOI: 10.3892/ol.2018.9525

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  43 in total

1.  Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart.

Authors:  William D Travis; Elisabeth Brambilla; Allen P Burke; Alexander Marx; Andrew G Nicholson
Journal:  J Thorac Oncol       Date:  2015-09       Impact factor: 15.609

2.  Primary pulmonary choriocarcinoma--a series of 7 cases.

Authors:  Pradeep Vaideeswar; Jay Mehta; Jaya Deshpande
Journal:  Indian J Pathol Microbiol       Date:  2004-10       Impact factor: 0.740

3.  Primary pulmonary choriocarcinoma combined with adenocarcinoma.

Authors:  Sohei Yamamoto; Hiroyuki Tanaka; Hiroaki Takeo; Kazuyo Yasuda; Susumu Mastukuma
Journal:  Pathol Int       Date:  2006-07       Impact factor: 2.534

4.  Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens.

Authors:  Natasha Rekhtman; Daphne C Ang; Camelia S Sima; William D Travis; Andre L Moreira
Journal:  Mod Pathol       Date:  2011-05-27       Impact factor: 7.842

Review 5.  Combined choriocarcinoma and adenocarcinoma of the lung occurring in a man: case report and review of the literature.

Authors:  F Chen; A Tatsumi; S Numoto
Journal:  Cancer       Date:  2001-01-01       Impact factor: 6.860

Review 6.  Choriocarcinoma of the lung: report of a case.

Authors:  Takayuki Ibi; Kyoji Hirai; Ryuzo Bessho; Masashi Kawamoto; Kiyoshi Koizumi; Kazuo Shimizu
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-04-28

7.  Primary pulmonary choriocarcinoma in a male.

Authors:  Akberet Hadgu; Arshdeep Tindni; Mukta Panda
Journal:  BMJ Case Rep       Date:  2010-07-07

8.  P63 expression in gestational trophoblastic disease: correlation with proliferation and apoptotic dynamics.

Authors:  Hui-Juan Zhang; Wei-Chen Xue; Michelle Kwan-Yee Siu; Xiao-Yun Liao; Hextan Yuen-Sheung Ngan; Annie Nga-Yin Cheung
Journal:  Int J Gynecol Pathol       Date:  2009-03       Impact factor: 2.762

Review 9.  Primary choriocarcinoma of the lung.

Authors:  Yoshiki Umemori; Akio Hiraki; Keisuke Aoe; Tomoyuki Murakami; Tadashi Maeda; Eisuke Matsuda; Hiroyasu Takeyama
Journal:  Anticancer Res       Date:  2004 May-Jun       Impact factor: 2.480

10.  Primary choriocarcinoma of the lung.

Authors:  Y K Rhee; J H Kim; W H Kim; C Y Ha; K H You; D S Jang
Journal:  Korean J Intern Med       Date:  1987-07       Impact factor: 2.884

View more
  1 in total

1.  Pulmonary neuroendocrine tumors: study of 266 cases focusing on clinicopathological characteristics, immunophenotype, and prognosis.

Authors:  Shuwen Zhang; Jingjing Chen; Rui Zhang; Liqin Xu; Yan Wang; Zaixin Yuan; Xiaohui Hou; Jian Feng
Journal:  J Cancer Res Clin Oncol       Date:  2022-03-06       Impact factor: 4.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.